Objectives To establish recommendations for the management of comorbidities in patients with psoriatic disease (PsD).
Methods A multidisciplinary panel drafted the recommendationsin a nominal group session. Evidence from four systematic reviews was added. Agreement was assessed by two-rounds Delphi technique. Recommendations with an agreement ≥7/10 by at least 70% of participants were kept in.
Results A total of 19 recommendations on three key topics were issued: 1) screening of specific comorbidities, 2) specific preventive or therapeutic actions, and 3) general management.
Conclusions Disease control coupled with the management of comorbidities is critical to ensure optimal patient care. These recommendations suggest actions on detection, management and integration of care in PsD.
Acknowledgement GECOAP project was funded by Merck Sharp & Dohme of Spain
Disclosure of Interest None declared